Looking Beyond 2022 – Future Directions for CRISPR

Time: 8:45 am
day: Day Two


  • Outlining the latest advances and developments in CRISPR-based therapies, with a focus on in vivo applications
  • Exploring future directions for current gene editing companies including base, prime and epigenome editing technologies
  • Understand what current obstacles and challenges are holding in vivo gene editing therapeutics back from success